Iressa Proves Just As Effective As Chemotherapy For Lung Cancer
Sunday, December 7, 2008 - 20:35
in Health & Medicine
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of nonsmall cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial.
Read the whole article on Science Daily
More from Science Daily
Related
- Iressa proves just as effective as chemotherapy for lung cancerThu, 20 Nov 2008, 19:32:03 EST
- Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapyFri, 16 May 2008, 11:22:13 EDT
- Proton therapy may reduce serious side effect of lung cancer treatmentThu, 13 Nov 2008, 10:51:08 EST
- Experimental chemotherapy regimen shows promise in treating advanced lung cancerTue, 12 Aug 2008, 6:14:50 EDT
- Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancerThu, 13 Nov 2008, 15:22:04 EST